Literature DB >> 12628755

Neurobiological mediators of neuronal apoptosis in experimental neuroAIDS.

M T Corasaniti1, D Rotiroti, G Nappi, G Bagetta.   

Abstract

Neuronal loss has often been described at post-mortem in the brain neocortex of patients suffering from AIDS. Neuroinvasive strains of HIV infect macrophages, microglial cells and multinucleated giant cells but not neurones. Processing of the virus by cells of the myelomonocytic lineage yields viral products that, in conjunction with potentially neurotoxic molecules generated by the host, might initiate a complex network of events which leads neurones to death. In particular, the HIV-1 coat glycoprotein gp120 has been proposed as a likely aetiologic agent of the described neuronal loss because it causes death of neurones in culture. More recently, it has been shown that brain neocortical cell death is caused in rat by intracerebroventricular injection of a recombinant gp120 coat protein and this occurs via apoptosis. The latter observation broadens our knowledge in the pathophysiology of the reported neuronal cell loss and opens a new lane of experimental research for the development of novel therapeutic strategies to limit damage to the brain of patients suffering from HIV associated dementia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12628755     DOI: 10.1016/s0378-4274(02)00434-4

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  8 in total

1.  Characterization of cell death pathways in human immunodeficiency virus-associated encephalitis.

Authors:  Roberta Nardacci; Andrea Antinori; Luigi Maria Larocca; Vincenzo Arena; Alessandra Amendola; Jean-Luc Perfettini; Guido Kroemer; Mauro Piacentini
Journal:  Am J Pathol       Date:  2005-09       Impact factor: 4.307

2.  Altered Associations between Pain Symptoms and Brain Morphometry in the Pain Matrix of HIV-Seropositive Individuals.

Authors:  Deborrah Castillo; Thomas Ernst; Eric Cunningham; Linda Chang
Journal:  J Neuroimmune Pharmacol       Date:  2017-09-02       Impact factor: 4.147

Review 3.  Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: current status of dopamine system vulnerability in NeuroAIDS.

Authors:  Mark J Ferris; Charles F Mactutus; Rosemarie M Booze
Journal:  Neurosci Biobehav Rev       Date:  2008-03-18       Impact factor: 8.989

Review 4.  Converging roles for sphingolipids and cell stress in the progression of neuro-AIDS.

Authors:  Norman J Haughey; Joesph Steiner; Avindra Nath; Justin C McArthur; Ned Sacktor; Carlos Pardo; Veera Venkata Ratnam Bandaru
Journal:  Front Biosci       Date:  2008-05-01

5.  The glial response to CNS HIV infection includes p53 activation and increased expression of p53 target genes.

Authors:  Suman Jayadev; Bomy Yun; Huy Nguyen; Hideaki Yokoo; Richard S Morrison; Gwenn A Garden
Journal:  J Neuroimmune Pharmacol       Date:  2007-10-20       Impact factor: 4.147

Review 6.  Interactions between prostaglandins, leukotrienes and HIV-1: possible implications for the central nervous system.

Authors:  Jonathan Bertin; Corinne Barat; Sylvie Méthot; Michel J Tremblay
Journal:  Retrovirology       Date:  2012-01-11       Impact factor: 4.602

7.  Arachidonic Acid Cascade and Eicosanoid Production Are Elevated While LTC4 Synthase Modulates the Lipidomics Profile in the Brain of the HIVgp120-Transgenic Mouse Model of NeuroHIV.

Authors:  Nina Y Yuan; Ricky Maung; Ziying Xu; Xianlin Han; Marcus Kaul
Journal:  Cells       Date:  2022-07-05       Impact factor: 7.666

Review 8.  Apoptosis of uninfected cells induced by HIV envelope glycoproteins.

Authors:  Barbara Ahr; Véronique Robert-Hebmann; Christian Devaux; Martine Biard-Piechaczyk
Journal:  Retrovirology       Date:  2004-06-23       Impact factor: 4.602

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.